Report Detail
Global Glaucoma Pharmaceuticals Market Insights, Forecast to 2025
- RnM2390998 |
- 14 May, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Glaucoma is caused due to rise in the intraocular pressure, if persists may lead to permanent eye damage.This increased pressure damages the optic nerve which transmits message to the brain High pressure is built due to the blockage of the trabecular meshwork which results in the accumulation of aqueous humor. Depending on the size of trabecular meshwork blockage, glaucoma can be categorized as open angle and narrow closure glaucoma. In open angle glaucoma trabecular meshwork blockage is wider than narrow angle glaucoma. This disease results in various symptoms such as redness in eye, nausea, vomiting, narrowing in vision and pain. This disease can be diagnosed by measuring eye pressure through tonometry.
Key growth drivers of the market include rising ageing population, healthcare expenditures, medical coverage and new innovative combination drugs. The market players in medication as well as devices segments are totally different and somewhat very fragmented.
The global Glaucoma Pharmaceuticals market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glaucoma Pharmaceuticals market based on company, product type, end user and key regions.
This report studies the global market size of Glaucoma Pharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Glaucoma Pharmaceuticals in these regions.
This research report categorizes the global Glaucoma Pharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Glaucoma Pharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Acadia Pharmaceuticals Inc.
Allergan Inc.
Inotek Pharmaceuticals Corporation
Merck & Co. Inc.
Santen Pharmaceutical Co.Ltd.
Novartis International AG
Market size by Product
Prostaglandins Analogues (PGAs)
Non PGAs
Market size by End User
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Glaucoma Pharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Glaucoma Pharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Glaucoma Pharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Glaucoma Pharmaceuticals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Glaucoma Pharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Glaucoma Pharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Glaucoma Pharmaceuticals Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Glaucoma Pharmaceuticals Market Size Growth Rate by Product
- 1.4.2 Prostaglandins Analogues (PGAs)
- 1.4.3 Non PGAs
- 1.5 Market by End User
- 1.5.1 Global Glaucoma Pharmaceuticals Market Size Growth Rate by End User
- 1.5.2 Hospital Pharmacies
- 1.5.3 Private Clinics
- 1.5.4 Drug Stores
- 1.5.5 Retail Pharmacies
- 1.5.6 E-Commerce
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Glaucoma Pharmaceuticals Market Size
- 2.1.1 Global Glaucoma Pharmaceuticals Revenue 2014-2025
- 2.1.2 Global Glaucoma Pharmaceuticals Sales 2014-2025
- 2.2 Glaucoma Pharmaceuticals Growth Rate by Regions
- 2.2.1 Global Glaucoma Pharmaceuticals Sales by Regions
- 2.2.2 Global Glaucoma Pharmaceuticals Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Glaucoma Pharmaceuticals Sales by Manufacturers
- 3.1.1 Glaucoma Pharmaceuticals Sales by Manufacturers
- 3.1.2 Glaucoma Pharmaceuticals Sales Market Share by Manufacturers
- 3.1.3 Global Glaucoma Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
- 3.2 Glaucoma Pharmaceuticals Revenue by Manufacturers
- 3.2.1 Glaucoma Pharmaceuticals Revenue by Manufacturers (2014-2019)
- 3.2.2 Glaucoma Pharmaceuticals Revenue Share by Manufacturers (2014-2019)
- 3.3 Glaucoma Pharmaceuticals Price by Manufacturers
- 3.4 Glaucoma Pharmaceuticals Manufacturing Base Distribution, Product Types
- 3.4.1 Glaucoma Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Glaucoma Pharmaceuticals Product Type
- 3.4.3 Date of International Manufacturers Enter into Glaucoma Pharmaceuticals Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Glaucoma Pharmaceuticals Sales by Product
- 4.2 Global Glaucoma Pharmaceuticals Revenue by Product
- 4.3 Glaucoma Pharmaceuticals Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Glaucoma Pharmaceuticals Breakdown Data by End User
6 North America
- 6.1 North America Glaucoma Pharmaceuticals by Countries
- 6.1.1 North America Glaucoma Pharmaceuticals Sales by Countries
- 6.1.2 North America Glaucoma Pharmaceuticals Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Glaucoma Pharmaceuticals by Product
- 6.3 North America Glaucoma Pharmaceuticals by End User
7 Europe
- 7.1 Europe Glaucoma Pharmaceuticals by Countries
- 7.1.1 Europe Glaucoma Pharmaceuticals Sales by Countries
- 7.1.2 Europe Glaucoma Pharmaceuticals Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Glaucoma Pharmaceuticals by Product
- 7.3 Europe Glaucoma Pharmaceuticals by End User
8 Asia Pacific
- 8.1 Asia Pacific Glaucoma Pharmaceuticals by Countries
- 8.1.1 Asia Pacific Glaucoma Pharmaceuticals Sales by Countries
- 8.1.2 Asia Pacific Glaucoma Pharmaceuticals Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Glaucoma Pharmaceuticals by Product
- 8.3 Asia Pacific Glaucoma Pharmaceuticals by End User
9 Central & South America
- 9.1 Central & South America Glaucoma Pharmaceuticals by Countries
- 9.1.1 Central & South America Glaucoma Pharmaceuticals Sales by Countries
- 9.1.2 Central & South America Glaucoma Pharmaceuticals Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Glaucoma Pharmaceuticals by Product
- 9.3 Central & South America Glaucoma Pharmaceuticals by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Glaucoma Pharmaceuticals by Countries
- 10.1.1 Middle East and Africa Glaucoma Pharmaceuticals Sales by Countries
- 10.1.2 Middle East and Africa Glaucoma Pharmaceuticals Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Glaucoma Pharmaceuticals by Product
- 10.3 Middle East and Africa Glaucoma Pharmaceuticals by End User
11 Company Profiles
- 11.1 Acadia Pharmaceuticals Inc.
- 11.1.1 Acadia Pharmaceuticals Inc. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Acadia Pharmaceuticals Inc. Glaucoma Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Acadia Pharmaceuticals Inc. Glaucoma Pharmaceuticals Products Offered
- 11.1.5 Acadia Pharmaceuticals Inc. Recent Development
- 11.2 Allergan Inc.
- 11.2.1 Allergan Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Allergan Inc. Glaucoma Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Allergan Inc. Glaucoma Pharmaceuticals Products Offered
- 11.2.5 Allergan Inc. Recent Development
- 11.3 Inotek Pharmaceuticals Corporation
- 11.3.1 Inotek Pharmaceuticals Corporation Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Inotek Pharmaceuticals Corporation Glaucoma Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Inotek Pharmaceuticals Corporation Glaucoma Pharmaceuticals Products Offered
- 11.3.5 Inotek Pharmaceuticals Corporation Recent Development
- 11.4 Merck & Co. Inc.
- 11.4.1 Merck & Co. Inc. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Merck & Co. Inc. Glaucoma Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Merck & Co. Inc. Glaucoma Pharmaceuticals Products Offered
- 11.4.5 Merck & Co. Inc. Recent Development
- 11.5 Santen Pharmaceutical Co.Ltd.
- 11.5.1 Santen Pharmaceutical Co.Ltd. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Santen Pharmaceutical Co.Ltd. Glaucoma Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Santen Pharmaceutical Co.Ltd. Glaucoma Pharmaceuticals Products Offered
- 11.5.5 Santen Pharmaceutical Co.Ltd. Recent Development
- 11.6 Novartis International AG
- 11.6.1 Novartis International AG Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Novartis International AG Glaucoma Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Novartis International AG Glaucoma Pharmaceuticals Products Offered
- 11.6.5 Novartis International AG Recent Development
12 Future Forecast
- 12.1 Glaucoma Pharmaceuticals Market Forecast by Regions
- 12.1.1 Global Glaucoma Pharmaceuticals Sales Forecast by Regions 2019-2025
- 12.1.2 Global Glaucoma Pharmaceuticals Revenue Forecast by Regions 2019-2025
- 12.2 Glaucoma Pharmaceuticals Market Forecast by Product
- 12.2.1 Global Glaucoma Pharmaceuticals Sales Forecast by Product 2019-2025
- 12.2.2 Global Glaucoma Pharmaceuticals Revenue Forecast by Product 2019-2025
- 12.3 Glaucoma Pharmaceuticals Market Forecast by End User
- 12.4 North America Glaucoma Pharmaceuticals Forecast
- 12.5 Europe Glaucoma Pharmaceuticals Forecast
- 12.6 Asia Pacific Glaucoma Pharmaceuticals Forecast
- 12.7 Central & South America Glaucoma Pharmaceuticals Forecast
- 12.8 Middle East and Africa Glaucoma Pharmaceuticals Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Glaucoma Pharmaceuticals Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Glaucoma Pharmaceuticals. Industry analysis & Market Report on Glaucoma Pharmaceuticals is a syndicated market report, published as Global Glaucoma Pharmaceuticals Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Glaucoma Pharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
